Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
25.7M
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
13.7M
-
Shares change
-
+7.99M
-
Total reported value, excl. options
-
$127M
-
Value change
-
+$73.4M
-
Number of buys
-
12
-
Number of sells
-
-8
-
Price
-
$9.19
Significant Holders of Benitec Biopharma Inc. - Common Stock (BNTC) as of Q3 2024
25 filings reported holding BNTC - Benitec Biopharma Inc. - Common Stock as of Q3 2024.
Benitec Biopharma Inc. - Common Stock (BNTC) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.7M shares
of 25.7M outstanding shares and own 53.39% of the company stock.
Largest 10 shareholders include SUVRETTA CAPITAL MANAGEMENT, LLC (8.83M shares), JANUS HENDERSON GROUP PLC (877K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (841K shares), Nantahala Capital Management, LLC (838K shares), FRANKLIN RESOURCES INC (797K shares), AWM Investment Company, Inc. (625K shares), Schonfeld Strategic Advisors LLC (273K shares), VANGUARD GROUP INC (213K shares), Simplify Asset Management Inc. (117K shares), and GEODE CAPITAL MANAGEMENT, LLC (84K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.